ERT Further Expands Executive Management Team

• 

I’m eager to get on the front line to ensure our customers have the products and services that will enable them to capture the highest quality safety and efficacy endpoint data possible

PHILADELPHIA, PA (PRWEB) September 16, 2013

ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an additional expansion of its executive management team. It has appointed Steven Herne as Executive Vice President and Chief Commercial Officer (CCO).

As CCO, Steven is responsible for all global business development activities within ERT. His primary objective is to ensure ERT’s products and services best meet the needs of its global biopharmaceutical and healthcare customers.

“We are thrilled to have Steven join our executive management team,” said Jeffrey Litwin, M.D., CEO of ERT. “His significant experience and understanding of our customers’ needs will prove extremely valuable as we continue to strengthen the breadth of services and solutions that ERT provides to the biopharmaceutical market.”

Steven has over 19 years of experience in the pharmaceutical industry, of which he spent the last 14 years focused intensively on business development, strategic development, product management, and marketing. Steven has held executive roles at major Contract Research Organizations (CROs), spanning the drug development spectrum with a key focus on customers and service delivery.

“I’m very excited to join ERT at this exciting time in the company’s growth,” said Steven. “I’m eager to get on the front line to ensure our customers have the products and services that will enable them to capture the highest quality safety and efficacy endpoint data possible,” said Steven.

For more information on ERT and its executive management team, visit http://www.ert.com/about-us/.

About ERT
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized cardiac safety, respiratory services, suicide risk assessment and Clinical Outcome Assessments (COA) – which includes patient, clinician, and observer reported outcomes. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes, and delivers safety and efficacy data critical to the approval, labeling, and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Japan, and Germany.

PDF Print